CHEK2 mutations and the risk of papillary thyroid cancer

M Siołek, C Cybulski, D Gąsior‐Perczak… - … Journal of Cancer, 2015 - Wiley Online Library
Mutations in the cell cycle checkpoint kinase 2 (CHEK2) tumor suppressor gene are
associated with multi‐organ cancer susceptibility including cancers of the breast and …

[PDF][PDF] CHEK2 mutations and the risk of papillary thyroid cancer

M Siołek, C Cybulski, D Gasior-Perczak, A Kowalik… - researchgate.net
We studied 468 unselected patients with papillary thyroid cancer (44 men and 424 women;
age at onset from 14 to 76 years, mean 48.2 years) diagnosed in a single oncology center …

CHEK2 mutations and the risk of papillary thyroid cancer

M Siołek, C Cybulski, D Gąsior-Perczak… - International Journal of …, 2015 - hero.epa.gov
Mutations in the cell cycle checkpoint kinase 2 (CHEK2) tumor suppressor gene are
associated with multi-organ cancer susceptibility including cancers of the breast and …

CHEK2 mutations and the risk of papillary thyroid cancer

M Siołek, C Cybulski, D Gąsior‐Perczak… - International Journal of …, 2015 - infona.pl
Mutations in the cell cycle checkpoint kinase 2 (CHEK2) tumor suppressor gene are
associated with multi‐organ cancer susceptibility including cancers of the breast and …

CHEK2 mutations and the risk of papillary thyroid cancer

M Siołek, C Cybulski… - … journal of cancer, 2015 - pubmed.ncbi.nlm.nih.gov
Mutations in the cell cycle checkpoint kinase 2 (CHEK2) tumor suppressor gene are
associated with multi-organ cancer susceptibility including cancers of the breast and …

CHEK2 mutations and the risk of papillary thyroid cancer.

M Siołek, C Cybulski, D Gąsior-Perczak… - … Journal of Cancer, 2015 - europepmc.org
Mutations in the cell cycle checkpoint kinase 2 (CHEK2) tumor suppressor gene are
associated with multi-organ cancer susceptibility including cancers of the breast and …